Hexagon Nutrition IPO is a book-built issue worth ₹138.87 crore. The issue is entirely an offer for sale of ₹138.87 crore. The IPO opens on June 5, 2026, and closes on June 9, 2026, with tentative listing on BSE and NSE on June 12, 2026.
The IPO is priced in the range of ₹42 to ₹45 per share, with a minimum investment of ₹14,985 for retail investors. Hexagon Nutrition Ltd. is a research-driven nutrition company engaged in manufacturing and developing nutrition and wellness products.
Let us understand the Hexagon Nutrition IPO in detail.
Hexagon Nutrition IPO – Key Details
The following are some of the important and key details about the Hexagon Nutrition IPO.
Particulars
Details
IPO Type
Book Building IPO
IPO Size
₹138.87 Cr
Fresh Issue
-
Offer for Sale
₹138.87 Cr
Price Band
₹42 – ₹45
Lot Size
333 shares
Listing
BSE, NSE
IPO Dates
Jun 5 – Jun 9, 2026
Hexagon Nutrition IPO Timeline
The following table explains the tentative IPO schedule.
Event
Date
IPO Opens
Jun 5, 2026
IPO Closes
Jun 9, 2026
Allotment
Jun 10, 2026
Refunds
Jun 11, 2026
Listing Date
Jun 12, 2026
Hexagon Nutrition IPO Lot Size & Investment
The following table shows the minimum and maximum investment required.
Category
Shares
Amount
Retail (Min)
333
₹14,985
Retail (Max)
4,329
₹1,94,805
sNII (Min)
4,662
₹2,09,790
bNII (Min)
22,311
₹10,03,995
About Hexagon Nutrition Ltd. Business Operations
Incorporated in 1993, Hexagon Nutrition Ltd. is a research-driven nutrition company engaged in developing and manufacturing products across micronutrient premixes, branded wellness and clinical nutrition, therapeutic formulations, and ready-to-use foods.
The company operates three manufacturing facilities in India, located at:
Nasik, Maharashtra
Chennai, Tamil Nadu
Thoothukudi, Tamil Nadu
It also operates an international manufacturing unit in Tashkent, Uzbekistan. Two Indian facilities are located in SEZ zones at Chennai and Thoothukudi.
Business Segments of Hexagon Nutrition Ltd.
The following are the core operating segments of Hexagon Nutrition Ltd.
Branded Wellness and Clinical Nutrition Products (B2C)
Premix Formulations (B2B2C)
Ready-to-Use Foods (RUFs) and Micronutrient Powders (MNPs)
Global Presence & Distribution Network
The following highlights the company’s operational scale.
PAN-India omnichannel distribution network
Presence across retail pharmacies, hospitals, e-commerce, and online pharmacies
Operates branded websites, including Pentasure, Obesigo, Pediagold, and Nutrone
Works with over 358 distributors across India
Overseas offices in South Africa, Uzbekistan, and Hong Kong
Exported products to more than 75 countries between FY23 and FY25
Two dedicated in-house R&D facilities at Nasik and Chennai
527 employees as of March 31, 2026
Competitive Strengths of Hexagon Nutrition Ltd.
The following are the key strengths of the company:
Research-driven nutrition business model
Diversified product portfolio across nutrition categories
Strategically located manufacturing facilities
Strong domestic and international distribution network
Dedicated in-house R&D facilities
Presence across multiple global markets
Hexagon Nutrition Ltd. – Financial Performance
The following table shows restated consolidated financials. (Amount in ₹ Crore)
Period
Total Income
PAT
EBITDA
FY23
281.65
5.82
17.17
FY24
305
12.21
24.88
FY25
331
24.38
40.07
Dec 2025
276
27.03
37.55
Key insight: The company has shown growth in income, profitability, and EBITDA across the reported periods.
Key Performance Indicators (KPI)
The following table highlights important valuation and profitability metrics:
Metric
Value
RoNW (Dec 2025)
12.12%
PAT Margin
9.81%
EBITDA Margin
14.03%
Price to Book
2
Market Capitalisation
₹553.13 Cr
Valuation Snapshot
The following table shows EPS and P/E comparison.
Particulars
Pre IPO
Post IPO
EPS (₹)
1.98
2.93
P/E (x)
22.69
15.35
Risks to Consider
Investors should be aware of the following risks.
Dependence on nutrition and wellness product demand
Competitive landscape in the nutrition and healthcare industry
Export market and international business exposure
Operational risks related to manufacturing and distribution
Summary
Hexagon Nutrition Ltd. operates in the nutrition and wellness segment with products spanning clinical nutrition, premixes, therapeutic formulations, and ready-to-use foods. The company has manufacturing facilities in India and overseas, supported by a broad domestic and international distribution network.
The IPO is entirely an offer for sale, and the company has shown growth in income and profitability over the reported periods. Its operations are supported by in-house R&D capabilities and exports across multiple countries.
This IPO may appeal to investors looking for:
Exposure to the nutrition and wellness sector
A company with a diversified nutrition product portfolio
Participation in domestic and international nutrition markets
Disclaimer
This content is for informational and educational purposes only and does not constitute investment advice. UnlistedKraft is not responsible for any losses arising from investment decisions based on this content. Readers should conduct their own research and consult qualified professionals before investing. IPO is expected to list on June 12, 2026, on BSE and NSE.
Frequently Asked Questions
What is the Hexagon Nutrition IPO?
Hexagon Nutrition IPO is a main-board IPO of ₹138.87 crore, entirely consisting of an offer for sale, priced at ₹42–₹45 per share.
When does the Hexagon Nutrition IPO open?
The Hexagon Nutrition IPO opens on June 5, 2026, and closes on June 9, 2026.
What is the lot size of the Hexagon Nutrition IPO?
The minimum lot size of the Hexagon Nutrition IPO is 333 shares.
Is Hexagon Nutrition Ltd. profitable?
Yes, Hexagon Nutrition Ltd. has reported profits across the reported financial periods, including FY23, FY24, FY25, and the latest interim period.
Who are the promoters of Hexagon Nutrition Ltd.?
The promoters of Hexagon Nutrition Ltd. are Arun Purushottam Kelkar, Subhash Purushottam Kelkar, Vikram Arun Kelkar, and Nikhil Arun Kelkar.
What does Hexagon Nutrition Ltd. do?
Hexagon Nutrition Ltd. develops and manufactures nutrition products, including premixes, wellness and clinical nutrition products, therapeutic formulations, and ready-to-use foods.
Author: Komal Bhatt
Komal Bhatt is a finance content writer at InvestKraft, specialising in well-researched articles on financial products, stock markets, and investment opportunities, with a particular focus on unlisted shares.
She holds a Master’s degree in Commerce from the University of Delhi, which gives her a solid academic foundation in finance and business. With over three years of hands-on experience in creating digital finance content, Komal has developed a clear understanding of investor needs through her work on wealth management, NISM certification programs, and market education materials.
Komal is passionate when it comes to breaking down complex financial concepts into simple, accurate and actionable insights. Her goal is to help everyday investors understand markets better and make more informed decisions based on reliable, research-backed information.